Document is current
Any future updates will be listed below
-
Authors
Nakamura, Hideaki
Watanabe, Tatsuro
Sato, Akemi
Kawaguchi, Atsushi
Uchimaru, Kaoru
Satou, Yorifumi
Sueoka, Eisaburo
-
Funding
Funding for this research was provided by:
Japanese Society for the Promotion of Science (20K07700)
Kurozumi Medical Foundation Grant
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 7 July 2025
First Online: 22 July 2025
Declarations
:
: Tatsuro Watanabe received research funding from OHARA Pharmaceutical Co., Ltd., and is currently employed by Meiji Seika Pharma Co., Ltd. Yorifumi Satou received research funding from Denka Co., Ltd., Meiji Seika Pharma Co., Ltd., and KM Biologics Co., Ltd. The remaining authors declare no conflicts of interest.
: The study protocol was approved by the Institutional Review Board of Saga University (24–52 and 2018-03-02). All cases in this study provided written informed consent before participating.
